Latest News about BMY
Recent news which mentions BMY
Cancer Drug Approval? 3 Biotech Stocks on the Brink of Breakthroughs
October 02, 2023
From InvestorPlace
Q4 Stock Predictions: 3 Pharma Stocks Ready to Roar Into 2024
October 02, 2023
From InvestorPlace
From Benzinga
As Merck, AstraZeneca and other drugmakers sign on, Medicare price negotiations face critical moment
September 29, 2023
From MarketWatch
From Benzinga
3 Dividend Stocks to Buy and Hold Until Retirement
September 28, 2023
From Motley Fool
Bristol-Myers Squibb Unusual Options Activity For September 27
September 27, 2023
Tickers
BMY
From Benzinga
3 Artificial Intelligence (AI) Stocks That Could Soar More Than Nvidia, According to Wall Street
September 25, 2023
From Motley Fool
Beware! 3 Healthcare Stocks Waving Massive Red Flags Right Now.
September 24, 2023
From InvestorPlace
Bristol Myers' Lead Cancer Drug Opdivo Regime Meets Primary Goal In Phase 3 Lung Cancer Study
September 22, 2023
Tickers
BMY
From Benzinga
Quant Ratings Updated on 98 Stocks
September 19, 2023
From InvestorPlace
Anemia Advantage For GSK's Blood Cancer Therapy Could Influence Market Share Despite Incyte's Jakafi Comparison
September 18, 2023
From Benzinga
Looking Into Bristol-Myers Squibb's Recent Short Interest
September 18, 2023
Tickers
BMY
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
September 15, 2023
From Benzinga
The 3 Most Undervalued Pharma Stocks to Buy in September 2023
September 14, 2023
From InvestorPlace
Bristol-Myers Squibb Plans To Double Clinical Pipeline Platforms To Support Long-Term Sustainable Growth
September 14, 2023
Tickers
BMY
From Benzinga
The Next Walgreens CEO? My Top 3 Picks to Replace Roz Brewer.
September 13, 2023
From InvestorPlace
2 Undervalued Dividend Stocks to Buy Now
September 13, 2023
From Motley Fool
From Benzinga
Bristol Myers Squibb's Opdivo Plus Yervoy Combo Shows Durable, Long-Term Survival In Lung Cancer Patients
September 11, 2023
Tickers
BMY
From Benzinga
How A Small Indian Firm Firm Was Pulled Into A Legal Battle with Big Pharma Over A Cancer Drug
September 11, 2023
From Benzinga
The 3 Best Pharma Stocks to Buy Now: September 2023
September 08, 2023
From InvestorPlace
Bristol Myers' Antitrust Allegations: Lawsuit Over Alleged Patent Deception For Blood Cancer Drug
September 07, 2023
From Benzinga
How To Earn $500 From Pfizer Stock With Shares Trading At 52-Week Low
September 06, 2023
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
September 05, 2023
From Benzinga
Legal Twist In Drug Price Negotiation: Federal Judge Quits Case Amid Allegations Of Stock Ownership
September 05, 2023
From Benzinga
3 No-Brainer Dividend Stocks to Buy in September
September 02, 2023
From Motley Fool
8 Pharma Stocks Affected by New Drug Price Negotiation Rules
September 02, 2023
From Motley Fool
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.